Our Pipeline and Products

Menarini is investing in advanced science and technology to develop a pipeline of new products that make a difference to the lives of patients affected by serious conditions.

MENARINI is a fully integrated privately owned pharma company with a long and successful heritage in strategic partnering across the globe. We have a profound know-how stemming from our strong R&D capabilities in key therapeutic areas, coupled with our excellence in commercial execution and our powerful direct presence on a global basis.

Share your partnering idea

Our dedicated Corporate Business Development team is committed to assess and explore innovative new opportunities.

 

Donations of backpacks and cases for school, distribution of meals and medicines, promotion of sport, support for pregnant women and much more: being responsible for Menarini means transforming good intentions into concrete efforts. By helping others, we want to contribute to improve the world around us, starting with us.

Our Values

Everyday we put our values into action. 4 values, which have given life to Menarini and shaped its history.

 

What does it really make Menarini unique? The diversity and authenticity of our key resource - the People.
Our cultural diversity helps us to drive innovation, adapt to business changes, face challenges, inspire ideas and develop our growth.

Available positions on Linkedin

Menarini employees make all the difference, every day.

 

News

Malesci Congresses with "Zero Impact®" on the environment

The Malesci Pharmaceutical company, member of the Menarini Group, has enrolled in the innovative Lifegate Zero Impact® project, sponsoring scientific congresses organised with the environment in mind.

Zero Impact® is the first project in Italy to put into action the concepts laid down in the Kyoto protocol aimed at reducing the emissions of carbon dioxide and compensating any damage by planting trees to create new forests.

Even at the 2 nd International Cardio Event on Innovations in the field of Cardiology from a Clinical, Epidemiological and Methodological viewpoint, held last January and sponsored by Malesci in co-operation with LifeGate, the environmental impact in terms of CO 2 emissions generated by the event was assessed. Taking into account the amount of electricity used, the emissions generated by participants’ cars, as well as all other emissions of CO 2 and gases with a potential ‘greenhouse’ effect, LifeGate was able to calculate the number of square metres of trees and plants necessary to compensate for the total amount of emissions generated (hence rendering the event Zero Impact®!)

"The idea of compensating the ecological footprint left by the events we hold is the result of an assiduous focus on socio-environmental issues. Our commitment over the past two years has given us the opportunity to plant more than 25.000 square metres of forest in Costa Rica, one of the world’s greatest areas of biodiversity, and to reabsorb approximately 70.000 kgs of CO 2 . By doing this we are not only fulfilling our ethical and social obligations but also going beyond the limits established by the laws in force ", commented Dr. Bertolaccini, General Manager of Malesci.

Firenze, 02/02/2010